Toviaz Oral Tablet, Extended Release 4Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Toviaz: Oral tablet, extended release (4mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_11729.JPG
Toviaz 4mg ER Tab
Pfizer US Pharmaceuticals
Pill Identification: FS 

What is this Medicine?

FESOTERODINE (fes oh TER oh deen) is used to treat overactive bladder. This medicine reduces the amount of bathroom visits.

CVS Pharmacy Patient Statistics for Toviaz: Oral tablet, extended release(4mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information

Toviaz 4mg Extended-Release Tablet

NDC: 000690242
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Urinary Urgency, Urinary Incontinence, Overactive Bladder (OAB)

Storage Information
Protect from moisture
Store between 68 to 77 degrees F, excursions permitted 59 to 86 degrees F
Toviaz 4mg Extended-Release Tablet
Drug Image file DrugItem_11729.JPG
Pfizer US Pharmaceuticals
Pill Identification: FS 
Shape: oval
Color: blue

Reported Side Effects for Toviaz 4mg Extended-Release Tablet

Inability To Sleep Incidence:
0.4-1.3%*
Severity: MILD
Onset: EARLY
Elevated Hepatic Enzymes Incidence:
0.4-1.2%*
Severity: MODERATE
Onset: DELAYED
Stomach Pain Incidence:
0.5-1.1%*
Severity: MILD
Onset: EARLY
Skin Rash Incidence:
0.7-1.1%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
0.7-1.9%*
Severity: MILD
Onset: EARLY
Fluid Retention Incidence:
0.7-1.2%*
Severity: MODERATE
Onset: DELAYED
Back Pain Incidence:
0.9-2.0%*
Severity: MILD
Onset: DELAYED
Cough Incidence:
0.9-1.6%*
Severity: MILD
Onset: DELAYED
Retaining Urine Incidence:
1.1-1.4%*
Severity: MODERATE
Onset: EARLY
Painful Urination Incidence:
1.3-1.6%*
Severity: MODERATE
Onset: EARLY
Dry Eyes Incidence:
1.4-3.7%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
1.6-2.3%*
Severity: MILD
Onset: EARLY
Infection Incidence:
3.2-4.2%*
Severity: MILD
Onset: DELAYED
Constipation Incidence:
4.0-6.0%*
Severity: MODERATE
Onset: DELAYED
Dry Mouth Incidence:
19.0-35.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Toviaz 4mg Extended-Release Tablet

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Moderate Lifestyle Interaction
Grapefruit juice and Toviaz 4mg Extended-Release Tablet(Fesoterodine fumarate)
Grapefruit juice and Fesoterodine fumarate(Fesoterodine fumarate)
Side effects from Fesoterodine may get worse if you take grapefruit juice. Do not significantly alter your intake of grapefruit or grapefruit juice while taking Fesoterodine. Discuss any new or worsening side effects, such as constipation, dizziness, difficulty with urination, dry mouth and eyes, changes in vision, fast heartbeat, or confusion, with your health care provider.
Minor Lifestyle Interaction
Alcohol and Toviaz 4mg Extended-Release Tablet(Fesoterodine fumarate)
Alcohol and Fesoterodine fumarate(Fesoterodine fumarate)
The intake of Alcoholic beverages may decrease the actions of Fesoterodine because Alcohol may increase urination. You may wish to limit your intake of Alcoholic beverages while taking Fesoterodine. Do not drive or operate machinery until you know how these drugs affect you.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Toviaz

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.